Protein ingredients market was valued at $55 billion in 2025 and is projected to reach $94.7 billion by 2035, growing at a CAGR of 5.7% during the forecast Period (2026-2035). Increased funding is enhancing production capacity and scalability, enabling manufacturers to efficiently meet the growing global demand for sustainable, high-quality protein ingredients. This influx of capital is also supporting technological advancements and accelerating the commercialization of innovative protein solutions, particularly in alternative protein segments. As a result, investment activity continues to play a crucial role in strengthening supply chains and expanding market reach. For instance, in September 2025, NxtFood raised $58 million in a Series B funding round, one of the largest recent investments in protein innovation, supporting the expansion of plant-based protein technologies.

Global SerDes market is projected to grow from $1.7 billion in 2025 and is projected to reach $4.7 billion by 2035, growing at a CAGR of 10.5% during the forecast period 2026-2035. The global SerDes market is evolving rapidly as industries increasingly demand high-speed and reliable data transfer solutions. Growth is largely driven by the expansion of data centers, cloud computing services, and high-performance computing networks that require low-latency interconnects. The push for advanced telecommunications infrastructure, including 5G deployment, has heightened the need for efficient serialization and deserialization technologies. Automotive applications are also influencing market dynamics, with connected and autonomous vehicles relying on robust SerDes systems for in-vehicle communication. Additionally, industrial automation and smart manufacturing are creating opportunities for integrated SerDes solutions that can support complex control and monitoring systems. As organizations prioritize faster and more energy-efficient communication, the adoption of SerDes technology is becoming increasingly widespread.

Polyolefins market was valued at $255 billion in 2025 and is projected to reach $374.7 billion by 2035, growing at a CAGR of 4.0% during the forecast Period (2026-2035). New investments in large-scale polyolefin production facilities are boosting global output, aligning supply with the increasing demand across various end-use industries, thereby driving market growth. For instance, in March 2026, the Borouge 4 (B4) petrochemical expansion in Abu Dhabi involves approximately $6.2?billion in investment to add new polyolefin production units, including additional PE lines and associated infrastructure. This expansion is expected to bolster output from one of the world’s largest integrated polyolefins complexes.

Penicillin and streptomycin market was valued at $3.3 billion in 2025 and is projected to reach $6.5 billion by 2035, growing at a CAGR of 7.0% during the forecast Period (2026-2035). Regulatory approvals for locally manufactured penicillin derivatives have enhanced production capacity, ensuring a steady supply of antibiotics and reducing shortages, thereby stimulating growth in the penicillin and streptomycin market. For instance, in December 2025, the US FDA approved a US-manufactured version of amoxicillin–clavulanate (Augmentin XR) under a priority review program aimed at strengthening domestic antibiotic supply chains. This approval is significant for the penicillin class, as amoxicillin is a key penicillin derivative, and the initiative focuses on reducing antibiotic shortages, improving local manufacturing capacity, and ensuring the consistent availability of essential antibiotics. 

Lung cancer diagnostics treatment market was valued at $30.3 billion in 2025 and is projected to reach $52.7 billion by 2035, growing at a CAGR of 5.8% during the forecast Period (2026-2035). The expansion of biomarker-driven therapies is evident, as regulatory approval of HER2-targeted treatments highlights the move towards precision oncology, which in turn fuels demand for advanced molecular and genomic diagnostics in lung cancer care. For instance, in February 2026, the FDA granted accelerated approval of zongertinib (Hernexeos) for adults with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) with HER2 tyrosine kinase domain-activating mutations, as part of the FDA's CNPV pilot program. The Beamion LUNG-1 trial involving 72 patients showed an objective response rate of 76%, with 64% of responders having a duration of response of at least 6 months. Warnings include hepatotoxicity, left ventricular dysfunction, interstitial lung disease/pneumonitis, and embryo-fetal toxicity. Recommended dosages are 120 mg daily for patients under 90 kg and 180 mg for those 90 kg or more, taken with or without food.

Infertility diagnosis and treatment market was valued at $7.4 billion in 2025 and is projected to reach $16.2 billion by 2035, growing at a CAGR of 8.2% during the forecast Period (2026-2035). FDA clearance enhances the credibility of next-generation fertility therapies, promoting their global adoption and driving the market growth of advanced infertility treatments. For instance, in January?2025, the US Food and Drug Administration (FDA) granted clearance for a phase?3 clinical trial of Fertilo, an innovative fertility therapy based on induced pluripotent stem cells (iPSCs). This treatment aims to mature eggs outside the body using lab?grown ovarian support cells, significantly reducing hormone stimulation needs in IVF protocols. The phase?3 trial, conducted across 15 U.S. sites, is a key step toward wider clinical use and represents one of the most advanced new reproductive therapeutics in recent years.

Healthcare BPO market was valued at $417.8 billion in 2025 and is projected to reach $1,053.7 billion by 2035, growing at a CAGR of 9.8% during the forecast Period (2026-2035). Investment in AI-driven solutions significantly enhances the efficiency of outsourced financial operations in healthcare, leading to faster claims processing, increased billing accuracy, and lower administrative costs, thus driving market growth in AI-enabled Revenue Cycle Management (RCM).  For instance, in February?2026, Care.fi, a healthcare?focused fintech building an AI?powered revenue cycle management (RCM) infrastructure for hospitals, secured $8?million in a Series?A funding round. 

Fuel delivery system market was valued at $32.4 billion in 2025 and is projected to reach $43.4 billion by 2035, growing at a CAGR of 3.0% during the forecast Period (2026-2035). Increasing demand for high-performance fuel delivery systems in off-highway applications like construction and mining is fueling innovation in heavy-duty diesel fuel technologies, thereby driving market growth. For instance, in July 2025, Cummins Inc. launched a new advanced diesel fuel system designed for non-road and off-highway applications such as construction, mining, and power generation. The system is built on a heavy-duty oil-lubricated pump platform, offering improved durability, scalability, and high-performance fuel delivery under demanding operating conditions.

Disposable medical sensors market was valued at $13.2 billion in 2025 and is projected to reach $30.2 billion by 2035, growing at a CAGR of 8.8% during the forecast Period (2026-2035). Regulatory advancements in non-chemical disinfection technologies are promoting hygienic, single-use medical solutions, which in turn boost the demand for disposable medical sensors and drive market growth. For instance, in April 2025, UV Smart received FDA 510(k) clearance for its D60 UV-C disinfection device, designed for sterilizing TEE probes used in heart examinations. Claimed to be the first of its kind to gain this approval, the D60 significantly reduces disinfection time from approximately two hours using chemicals to just two minutes with UV-C light. This advancement enhances healthcare efficiency, increases patient throughput, and minimizes costs associated with chemical cleaning and equipment maintenance.

Global semiconductor gases market is projected to grow from $11.6 billion in 2025 and is projected to reach $23.6 billion by 2035, growing at a CAGR of 7.4% during the forecast period 2026-2035. The global semiconductor gases market is shaped by several real?world trends linked to the dynamics of advanced chip fabrication and supply chain structures. Rising demand for high?performance electronics and next?generation technologies has increased consumption of both specialty and bulk gases that are integral to deposition, etching, and chamber cleaning processes. Fabricators are placing greater emphasis on ultra?high purity gases as process nodes shrink and yield sensitivities grow, requiring stringent quality controls and reliable delivery systems. Concurrently, supply chains have become more complex and geographically distinct, with concentrated production hubs for critical gases such as helium and ultra?high?purity nitrogen creating vulnerability when disruptions occur. Geopolitical tensions and logistics bottlenecks have underscored how interdependencies can affect availability, prompting industry participants to reassess resilience strategies.